Agenus Inc AGEN

NAS: AGEN | ISIN: US00847G7051 15/09/2025

4,450 USD (-0,67%)

(-0,67%) 15/09/2025

Grafiek Agenus Inc

Grafiek Agenus Inc

1 dag1d -0,67%
1 week1w -12,23%
1 maand1m -1,77%
3 maanden3m -13,42%
6 maanden6m 150,00%
1 jaar1j -26,81%
5 jaar5j -12,92%

Agenus Inc in het nieuws

Toon enkel gratis nieuws

28 augustus 2025 · FDA Tightens Survival Standards as Cancer Drug Pipeline Hits $866B Market Milestone · Persbericht

29 juli 2025 · Biotech Underdogs Line Up for Pivotal Shots at Game-Changing Cancer Treatments · Persbericht

22 juli 2025 · From Diagnosis to Surgery: How AI Tech Is Quietly Reshaping Healthcare Profits · Persbericht

12 september 2024 · AGEN Investors Have Opportunity to Lead Agenus Inc. Securities Fraud Lawsuit · Persbericht

15 februari 2024 · Ginkgo Bioworks and SaponiQx Awarded MCDC Contract to Discover and Manufacture Next-Generation Vaccine Adjuvants Using Generative Molecular Design · Persbericht

15 maart 2021 · Agenus Corporate Update and Fourth Quarter & Full Year 2020 Financial Report · Persbericht

10 maart 2021 · Agenus to Present New Clinical Data on AGEN1181 at AACR 2021 · Persbericht

9 februari 2021 · Andy Hurley Named Agenus Chief Commercial Officer · Persbericht

9 februari 2021 · Agenus Announces Agenus Insights - Virtual R&D Miniseries · Persbericht

9 februari 2021 · Agenus Announces New Responses for AGEN1181 · Persbericht

Profiel Agenus Inc

Gezondheidstechnologie

Productie van biologische producten

Website: agenusbio.com

Hoofdzetel: Lexington, Massachusetts Verenigde Staten

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe